---
title: "Boehringer Ingelheim International GmbH v Zentiva Portugal, LDA. (UPC CoA 446/2025, 13-08-2025)"
description: "The Court of Appeal granted Boehringer Ingelheim a provisional injunction against Zentiva's nintedanib generics in all 17 UPC states where EP 1 830 843 is in…"
url: https://pitch.law/academy/upc-court-of-appeal/upc-coa-446-2025-2025-08-13
lang: en
author: "UPC Case Law by Pitch"
editor: "Bart Lieben"
datePublished: 2026-11-18T10:07:23.505Z
dateModified: 2026-11-18T10:07:23.505Z
---

# Boehringer Ingelheim International GmbH v Zentiva Portugal, LDA.

Order of the UPC Court of Appeal of 13 August 2025, UPC CoA 446/2025.

UPC Case Law by Pitch, edited by [Bart Lieben](https://pitch.law/team/bart-lieben) · Published 18-11-2026

## TL;DR

The Court of Appeal granted Boehringer Ingelheim a provisional injunction against Zentiva's nintedanib generics in all 17 UPC states where EP 1 830 843 is in force. It held that completing Portugal's pricing and reimbursement procedure more than a year before patent expiry amounted to an imminent infringement. Generics companies that clear national price and reimbursement steps early now face pre-launch injunctions even before any offer is made.

## Key holding

Under Art 62(1) and (4) UPCA and R 206.2(c) RoP, an infringement is imminent where the potential infringer has set the stage, so that infringement is only a matter of starting the action because preparations are fully completed. Applying for or obtaining a marketing authorisation for a generic medicine does not by itself create an imminent infringement. Completing the national procedures for health technology assessment, pricing and reimbursement can do so, assessed against the national regulatory context and the circumstances of the case. Taking part in public procurement with an infringing product is 'offering' under Art 25 UPCA, whether or not national law classifies the procedure as pre-contractual.

## Questions decided

1. Does applying for or obtaining a marketing authorisation for a generic amount to imminent infringement?
2. Can completing pricing and reimbursement procedures amount to imminent infringement?
3. Is participation in public procurement 'offering' under Art 25 UPCA?
4. Should the draft EU pharma Bolar provision shape the imminence test?
5. Can an information order under Art 67 UPCA be granted for a merely imminent infringement?
6. Who must prove the content of national law under Art 24 UPCA?

## Case details

- Court: Court of Appeal of the Unified Patent Court, Panel 2
- Panel: Rian Kalden (presiding judge, legally qualified judge); Ingeborg Simonsson (legally qualified judge, judge-rapporteur); Patricia Rombach (legally qualified judge); Andreas Gustafsson (technically qualified judge); Carola Wagner (technically qualified judge)
- Date: 13-08-2025
- Case number(s): UPC CoA 446/2025, UPC CoA 520/2025, UPC CFI 41/2025
- Parties: Appellant and respondent in the cross-appeal: Boehringer Ingelheim International GmbH (applicant at first instance); Respondent and cross-appellant: Zentiva Portugal, LDA. (defendant at first instance)
- Language of the proceedings: English
- Outcome: The Court of Appeal set aside the Lisbon order. It ordered Zentiva to refrain, in all 17 listed Contracting Member States, from making, offering, placing on the market, using, importing or storing nintedanib products for IPF (in particular Nintedanib Zentiva 100 mg and 150 mg) while the patent is in force, subject to a recurring penalty payment of up to €10,000 per package.
- Official text on the court’s website (PDF): https://www.unified-patent-court.org/sites/default/files/files/api_order/7A7FFD070CC8131C27B3E40343EEDD74_en.pdf

## How to cite

Court of Appeal, Boehringer Ingelheim International GmbH v Zentiva Portugal, LDA., UPC CoA 446/2025, UPC CoA 520/2025, Order of 13 August 2025 (OSCOLA)

## Full summary

Read the full analyses for free — create a free account: https://pitch.law/academy/upc-court-of-appeal/upc-coa-446-2025-2025-08-13

Topics: [Provisional measures](https://pitch.law/academy/upc-court-of-appeal/topics/provisional-measures), [Infringement and claim interpretation](https://pitch.law/academy/upc-court-of-appeal/topics/infringement), [Evidence, inspection and information](https://pitch.law/academy/upc-court-of-appeal/topics/evidence), [Procedure](https://pitch.law/academy/upc-court-of-appeal/topics/procedure)

## In the same case

- [Boehringer Ingelheim International GmbH v Zentiva Portugal, LDA. (application by Gowling WLG), UPC CoA 9/2026, 24-02-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-9-2026-2026-02-24): A third party seeking access to written pleadings and evidence under R 262.1(b) RoP must apply separately to each instance: documents lodged at the Court of First Instance are requested from the relevant Division, and documents lodged on appeal from the Court of Appeal.

## More on provisional measures

- [Guardant Health, Inc. v Sophia Genetics SA and others, UPC CoA 49/2026, 05-11-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-49-2026-2026-11-05): The Court of Appeal set aside a EUR 600,000 award of representation costs because the successful party had backed it only with invoices reading "supply of legal services" and general assertions about complexity and urgency.
- [SharkNinja Operating LLC v Groupe SEB France and others, UPC CoA 61/2026, 21-08-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-61-2026-2026-08-21): The Court of Appeal overturned the Paris Local Division and granted SharkNinja a provisional injunction in France and Germany against SEB's "Cookeo Infinity" multicookers.
- [Amazon.com, Inc. and others v InterDigital VC Holdings, Inc. and others, UPC CoA 936/2025, 15-07-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-936-2025-2026-07-15): The Court of Appeal permitted InterDigital to withdraw its application for provisional measures against Amazon while Amazon's appeal was pending, and declared the proceedings closed.
- [AIM Sport Development AG v TGI Sport Suomi Oy and others, UPC CoA 108/2026, 08-07-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-108-2026-2026-07-08): The Court of Appeal's judge-rapporteur held that an appeal against a first-instance order disposing of an application for provisional measures is an appeal against a final decision under R 220.1(a) RoP, because R 363.2 RoP gives such orders that status.
- [Angelalign Technology Inc. and others v Align Technology, Inc., UPC CoA 36/2026, 08-07-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-36-2026-2026-07-08): The Court of Appeal rejected Angelalign's appeal and upheld the Düsseldorf preliminary injunction against the "Live Now" feature of its iOrtho orthodontic planning software.
